Go Pro

KraneShares MSCI All China Health Care Index ETF (KURE) Holdings List

$19.02 -0.32 (-1.65%)
Closing price 09/23/2026 04:10 PM Eastern
Extended Trading
$18.99 -0.03 (-0.14%)
As of 09/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

What stocks does KURE hold?

The KraneShares MSCI All China Health Care Index ETF (KURE) top stock holdings include Innovent Biologics, Inc., BeOne Medicines AG, and WuXi Biologics (Cayman) Inc.. The top 25 KURE holdings ordered by weight make up 83.72% of the total fund. KURE is an equity fund in the sector category that invests in investments, focused on health care strategies within the Asia-Pacific region. This page includes a complete KURE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 KURE Holdings

RankCompanyCurrent PriceWeightShares Held
1Innovent Biologics, Inc.N/A8.91%777,000
2BeOne Medicines AGN/A8.77%348,518
3WuXi Biologics (Cayman) Inc.N/A7.64%1,278,635
4WuXi AppTec Co., Ltd.N/A5.90%263,320
5Shenzhen Mindray Bio-Medical Electronics Co., Ltd.N/A4.51%206,055
6Jiangsu Hengrui Pharmaceuticals Co.,LtdN/A4.33%718,308
7Akeso, Inc.N/A4.15%383,000
8Sino Biopharmaceutical LimitedN/A3.82%5,825,750
9CSPC Pharmaceutical Group LimitedN/A3.52%3,332,889
10WuXi AppTec Co., Ltd.N/A3.28%139,084
11Genscript Biotech CorporationN/A3.18%716,000
12Hansoh Pharmaceutical Group Company LimitedN/A3.03%740,000
13Yunnan Baiyao Group Co.,LtdN/A2.28%318,427
143SBio Inc.N/A2.15%1,130,500
15Shanghai United Imaging Healthcare Co., Ltd.N/A2.06%147,088
16Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.N/A2.02%36,700
17Aier Eye Hospital Group Co., Ltd.N/A1.84%1,659,763
18Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.N/A1.77%107,634
19Sichuan Biokin Pharmaceutical Co.,Ltd.N/A1.63%47,894
20Pharmaron Beijing Co., Ltd.N/A1.61%263,675
21Sichuan Kelun Pharmaceutical Co., Ltd.N/A1.59%283,816
22Asymchem Laboratories (Tianjin) Co., Ltd.N/A1.54%59,400
23Sinopharm Group Co. Ltd.N/A1.43%797,200
24Haisco Pharmaceutical Group Co., Ltd.N/A1.39%159,800
25XtalPi Holdings LimitedN/A1.37%1,661,000

KURE Geographic Exposure

KURE's largest geographic exposure is China at 37.7%, followed by Cayman Islands at 26.2%.

  • China
    37.7%
  • Cayman Islands
    26.2%
  • Hong Kong
    11.5%
  • United States
    2.2%

KURE Currency Exposure

KURE's largest currency exposure is HKD at 40.0%, followed by CNY at 27.8%.

  • HKD
    40.0%
  • CNY
    27.8%

KURE Sector Exposure

KURE's largest sector exposure is Health Care at 89.3%, followed by Real Estate at 1.0%.

  • Health Care
    89.3%
  • Real Estate
    1.0%
  • Consumer Staples
    0.9%

KURE Industry Exposure

KURE's largest industry exposure is Biotechnology at 51.2%, followed by Life Sciences Tools & Services at 15.9%.

  • Biotechnology
    51.2%
  • Life Sciences Tools & Services
    15.9%
  • Health Care Equipment & Supplies
    8.3%
  • Pharmaceuticals
    6.0%
  • Health Care Providers & Services
    3.3%
  • Health Care Technology
    2.4%
  • Health Care Equipment & Suppli
    2.0%
  • Diversified REITs
    1.0%
  • Food Products
    0.9%

KURE Sub-Industry Exposure

KURE's largest sub-industry exposure is Biotechnology at 47.8%, followed by Life Sciences Tools & Services at 15.9%.

  • Biotechnology
    47.8%
  • Life Sciences Tools & Services
    15.9%
  • Health Care Equipment
    8.8%
  • Pharmaceuticals
    7.6%
  • Health Care Services
    3.3%
  • Health Care Distributors
    2.4%
  • Diversified REITs
    1.0%
  • Packaged Foods & Meats
    0.9%

Related Companies and Tools


MarketBeat tracks KraneShares MSCI All China Health Care Index ETF holdings and portfolio composition, last updated on 9/19/2026.
From Our Partners